Enochian BioSciences Inc. is a pre-clinical stage biotechnology company. The Company uses its cell, gene and immune therapy technologies for the treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, as well as to provide cancer remission in some of the deadliest cancers. The CompanyÔÇÖs product candidates include ENOB-HV-01, an autologous transplant with genetically modified cells; ENOB-HV-11 and ENOB-HV-12, preventive and therapeutic vaccines; ENOB-HV-21, immunotherapy with allogeneic NK/GDT cells; ENOB-HV-31, in Vivo gene therapy; ENOB-HB-01, potential cure for HBV; ENOB-CV-01, Aerosol/Inhaled treatment potentially for all Coronaviruses that cause human disease; ENOB-CV-11, Aerosol/Inhaled prophylaxis potentially for all coronaviruses that cause human disease; ENOB-FL-01 Aerosol/Inhaled treatment potentially for all influenza viruses; and ENOB-FL-11, Aerosol/Inhaled prophylaxis potentially for all influenza viruses.
Number of employees : 11 people.
|Vote ||Quantity||Free-Float||Company-owned shares||Total Float
|Carl Sandler ||13,259,533||
|Serhat Gumrukcu ||10,446,171||
|Rs Group ApS ||9,668,351||
|Sabby Capital LLC ||1,341,663||
|The Vanguard Group, Inc. ||265,200||
|Geode Capital Management LLC ||148,059||
|Millennium Management LLC ||116,666||
|Dimensional Fund Advisors LP ||80,825||
|Virtu Financial BD LLC ||68,007||
|Mark Richard Dybul ||66,196||
|Company contact information|
Enochian Biosciences, Inc.
2080 Century Park East
Los Angeles, CA 90067-2012
Phone : +1.305.918.1980
Web : http://www.enochianbio.com
Sector Bio Therapeutic Drugs
Connections : Enochian Biosciences, Inc.